MedTrace Logo

Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder

NCT04797962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-03-22

No results posted yet for this study

Summary

The overarching goal of the study is to develop, pilot, and evaluate an intervention that aims to retain patients who initiate buprenorphine at Denver Health in ongoing treatment for opioid use disorder.

Conditions

  • Opioid-use Disorder

Interventions

BEHAVIORAL

Case management

dedicated case management to address social support needs

Sponsors & Collaborators

Principal Investigators

  • Alia Al-Tayyib, PhD · Denver Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2022-08-08
Completion
2023-09-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797962 on ClinicalTrials.gov